Become a consultant on Leadvisor
Reach clients worldwide and monetize your expertise — register your firm to get startedRegister as ConsultantLead to the right advice globally
Describe your professional need to reach the right professionals and services worldwide
9–10 September 2026 · Shangri-La Qiantan, Shanghai
2026 International Conference on Chinese Enterprise Globalization & Global Professional Services
China's Opportunities amid the Reshaping of the Global Services Network — 200+ Chinese enterprises, joined by professionals from 50+ countries and regions across five continents.
Key Regions
Solutions
Explore tailored solutions addressing key business challenges across industries and regions
Anti-dumping, Countervailing & Trade Remedies
Support investigations and proceedings for anti-dumping, countervailing, safeguards, and other trade remedies, including evidence preparation and hearing strategy.
Antitrust / Merger Control Filings
Prepare and submit merger control notifications, manage authority engagement, and coordinate remedies to secure antitrust clearance on time.
Audit Services
Provide statutory and special-purpose audits, assisting with financial statement assurance, internal control review, and reporting requirements for stakeholders and regulators.
Backdoor Listing / Reverse Takeover
Advise on backdoor listings and reverse takeovers, including target selection, transaction structuring, regulatory pathways, and disclosure compliance.
China ODI Approval / Filing
Support China outbound investment (ODI) approval/filing with NDRC/MOFCOM and related foreign exchange procedures, ensuring end-to-end regulatory compliance.
Customs Compliance Services
Deliver customs compliance advisory, including HS classification, valuation, origin rules, audit support, and risk mitigation for cross-border trade.
Cybersecurity & Data Protection
Provide cyber security and data protection advisory, including governance, incident response readiness, remediation, and compliance for cross-border data transfers.
Dispute Resolution
Handle commercial dispute resolution through negotiation, mediation, arbitration, and litigation, with strategy design and end-to-end case management.
Due Diligence
Conduct legal, financial, tax, and compliance due diligence to identify key risks, validate assumptions, and support decision-making and deal structuring.
Environmental Compliance
Advise on environmental compliance, permitting, EHS management, and sustainability requirements, helping clients assess and remediate environmental risks.
Export Controls & Compliance
Build export control compliance programs, classify controlled items, screen parties, manage licensing, and respond to enforcement inquiries across jurisdictions.
Host Country Investment Approvals
Obtain host-country investment approvals and sectoral permits, including foreign investment reviews, licensing, and registrations to enable smooth project implementation.
Human Resources
Provide HR advisory across hiring, compensation, policies, and labor compliance, including cross-border assignments and workforce optimization.
Initial Public Offering (IPO) & Listing
Guide IPO readiness and listing execution, including governance enhancement, regulatory compliance, prospectus support, and coordination with intermediaries.
Insolvency & Restructuring
Advise on insolvency proceedings and restructuring plans, including creditor negotiations, debt reorganization, and asset dispositions to preserve value and continuity.
International Engineering Contracting (EPC)
Advise on international engineering contracting (EPC), covering bid strategy, contract drafting/negotiation, claims management, compliance, and dispute prevention.
International Logistics
Provide international logistics planning and coordination, optimizing routes, costs, and timelines while aligning with trade terms, customs requirements, and risk controls.
Investment Agreement Drafting & Review
Draft, review, and negotiate investment agreements (term sheets, SPA/SSA, shareholders' agreements), aligning risk allocation, control rights, and closing conditions.
Investment Target Screening & Matching
Screen, benchmark, and match investment targets to client strategy through industry mapping, financial filters, and fit assessments to build a qualified pipeline.
Legal Entity Establishment & Maintenance
End-to-end incorporation and lifecycle maintenance, including registrations, corporate secretarial filings, governance updates, and ongoing compliance in relevant jurisdictions.
Life Sciences
Offer life sciences regulatory and transaction support, covering market access, clinical/quality compliance, licensing, and industry-specific risk management.
Ongoing Legal Counsel
Serve as ongoing legal counsel, providing day-to-day advisory, contract review, compliance support, and rapid response for operational legal issues.
Other Trade-related Services
Offer trade-related support such as trade finance, trade insurance, customs clearance/inspection, agency services, export tax rebates, and product certification & testing.
Securities / Funds / Futures / Insurance / Credit
Advise on financial services matters across securities, funds, futures, insurance, and credit, including licensing, compliance, product structuring, and reporting.
Tax Planning
Design tax-efficient structures, manage transfer pricing considerations, mitigate double taxation, and support filings to optimize tax costs while maintaining compliance.
Technology & Intellectual Property
Support technology and IP strategy, including IP portfolio planning, filings, licensing, technology transfer, and protection of core innovations.
Services
Tailored professional services provided through our global network of consulting firms
Contract Review
AI accelerates the review, licensed lawyers sign off — built for routine contracts.
Beijing Tigermed-Jyton Co., LTD. ——Project Management
We have a senior project management team with years of expertise in various fields such as medical aesthetics, cardiovascular, ophthalmology, AI, surgical robots, and oncology. We have built thorough analysis of the current situation and future developments in these fields. Relying on a strong medical team and years of solid cooperation with the study sites, we have accumulated unique advantages and rich experiences in the project management for innovative devices. Tigermed-Jyton is customer-oriented and adopts a project management model where the project manager serves as a one-stop contact point for the sponsors, assisting them in coordinating other functional teams to improve communication efficiencies. The project manager regularly analyzes the deviations between plans and actual progress, as well as manages and prevents risks, ensuring that the project proceeds as scheduled. 1. Preparation of project plan 2. Clinical trial risk management 3. Clinical trial document management 4. Clinical trial financial management 5. Clinical trial meeting organization 6. Project training 7. Relevant supplier management
泰格捷通(北京)医药科技有限公司
Beijing Tigermed-Jyton Co., LTD. ——Clinical Monitoring
We have a monitoring team with more than 200 CRAs in China, and more than 800 CRAs globally. We can provide local clinical monitoring and site management services. We are familiar with the study site process, and provide more convenient support and more professional services for the study sites. Our services include: 1. Study site screening 2. Ethics Committee filing and approval 3. Study site clinical trial agreement negotiation 4. Study site initiation and close-out 5. Study site monitoring and management 6. Investigational product management
泰格捷通(北京)医药科技有限公司
Beijing Tigermed-Jyton Co., LTD. ——Medical Writing
The medical writing team consists of dozens of excellent medical experts, writing specialists and statisticians. Core members have an average industry experience of more than 10 years and academic background of leading medical schools globally. Our innovative protocol design concept, scientific and rigorous work style, rich medical writing experience and effective SOPs have won the team a good reputation in the industry. Our service content includes the following: 1. Design of clinical trial protocols for medical devices / different phases of clinical trial protocols or unconventional study protocols for drugs 2. Preparation of clinical protocol related documents (e.g., case report forms, informed consent forms, and investigator’s brochure) 3. Preparation of clinical study report 4. Publishing papers on core journals 5. Preparation of medical materials for clinicians (e.g., questionnaire on updating treatment guidelines)
泰格捷通(北京)医药科技有限公司
Beijing Tigermed-Jyton Co., LTD. —— Clinical Evaluation Report
Medical device clinical evaluation refers to the process where the manufacture validates whether the product meets the operational requirements or falls within the applicable scope through clinical literature, clinical data, and clinical trial. We can provide Clinical Evaluation Report (CER) writing service that comply with regulatory requirements from both NMPA (National Medical Products Administration) and IMDRF (International Medical Device Regulators Forum) for regions covered by these regulations. Tigermed-Jyton has established partnerships with over a hundred well-known medical device companies globally. Most of the top 30 global medical device companies are our long-term clients. We have rapidly and professionally completed over 200 medical device clinical evaluation reports, covering more than 20 therapeutic areas, including cardiovascular, orthopedics, endocrinology, surgery, dentistry, imaging, and neurology, and others. Our team's strengths include reasonable and accurate technical comparisons, comprehensive and precise literature search and screening, rapid and accurate data extraction, adverse event information compilation, professional statistical analysis, and high-quality medical writing. With our extensive project experience and expertise, we are able to quickly and accurately write high-quality clinical evaluation reports in Chinese and English for medical device companies, including: Based on China's NMPA Requirements: 1. Clinical Evaluation Exemption Report: This report provides a comparison explanation for medical devices that are listed in the catalog for products exempted from clinical evaluation. 2. Predicate device clinical evaluation report 3. Overseas clinical trial / MRCT clinical evaluation report Based on EU MDR Requirements: EU MDR certified CER Clinical Evaluation Strategies and Scientific Evidence: 1. Feasibility assessment report of clinical evaluation pathway for product registration (Providing companies with registration / clinical evaluation pathway decision references based on their individual strategic business needs) 2. Clinical evaluation related literature search, screening, qualitative and quantitative analysis report 3. Meta-analysis 4. Systematic reviews 5. Journal writing & publication
泰格捷通(北京)医药科技有限公司
Beijing Tigermed-Jyton Co., LTD. ——GSP System Counseling
Medical device distributors should comply with the requirements of regulations such as the “Good Service Practice of Medical Device”. Our GSP compliance related consulting services include: 1. Collection and dissemination of medical device operation regulations 2. Establishment of management GSP system and personnel training 3. Business management software recommendation 4. Evaluation and selection of third-party distribution agencies 5. Business license data collection / application 6. Business management data analysis, statistics, application
泰格捷通(北京)医药科技有限公司
Beijing Tigermed-Jyton Co., LTD. ——MAH Counseling
MAH policy has effectively resolved the practical challenges faced by tech startups and research institutions in bringing their product to the market. It has addressed issues such as idle resources, manufacture facilities and equipment as well as insufficient work volume for skilled manufacturing personnel before their products’ marketization. Additionally, it prevents wastage of resources resulting from discrepancies between pre-market samples and post-market manufacturing, which includes the excessive utilization of funds before marketing and the extended recruitment of specialized personnel at various stages of manufacture. We provide the following related services: 1. Prompt dissemination of related regulations from various regions to ensure keeping up with the latest policy information 2. MAH mode planning, binding the 2 sets of supporting systems for R&D and manufacturing trustee 3. Trustee’s system evaluation to help license holder find suitable manufacturers 4. Establish quality systems and risk systems to provide the most reliable support for product marketing application 5. Simulation inspections of medical device GMP (Good Manufacturing Practice) to ensure a smooth inspection process for license holder 6. Supplier recommendation, covering from trustee manufacturers to product testing and raw material recommendation 7. System personnel training and assessment
泰格捷通(北京)医药科技有限公司
Beijing Tigermed-Jyton Co., LTD. ——GMP System Counseling
According to the requirements of the "Good Manufacturing Practice for Medical Devices", enterprises shall establish a quality management system suitable for the manufacturing and running of the medical devices and ensure their effective operation. Regarding the risk of medical devices, in order to manufacture safe, effective and quality standard compliant products, it is necessary to establish a set of quality systems based on hardware, supported by file system, and guaranteed by personnel, ensuring a systematic, coordinated and effective operation. We provide the following services: 1. Assessment of the existing systems and compliance gap analysis 2. Clean plant establishment and validation guidance 3. Common facilities verification counseling 4. Special process confirmation counseling 5. Design and development process support 6. Counseling / preparation / revision and improvement of quality system documents 7. Training and assessment of quality system personnel 8. Quality system manufacture workshop, manufacture equipment and other hardware compliance review 9. Quality system related regulations and knowledge training 10. Guide / accompany internal inspection / management review; 11. Medical device GMP system simulation assessment 12. Preparation, submission, tracking of quality system assessment materials until the inspection report is obtained 13. Writing / counseling of annual self-inspection report of medical device quality management system 14. Medical device product risk management periodic report writing / counseling 15. Quality management system improvement / rectification consultation
泰格捷通(北京)医药科技有限公司
Beijing Tigermed-Jyton Co., LTD. ——Testing Services
Our two medical device testing laboratories are located in Hangzhou and Suzhou, with 2000+ testing service item capabilities. We provide the following third-party tests: Medical device biocompatibility testing services (based on GB / T 16886, ISO10993 series standards) 1. Cytotoxicity test 2. Irritation test & skin sensitization test 3. Hemolysis test 4. Pyrogen test 5. Acute systemic toxicity test 6. Subacute / subchronic / chronic systemic toxicity test 7. Subcutaneous / muscle implantation test 8. In vivo degradation test 9. Genotoxicity test Animal testing studies 1. Animal efficacy studies 2. Animal pathology, toxicology research Physical and chemical characterization of medical devices 1. Material characterization 2. Chemical routine testing 3. Extractable and leachable studies 4. Chemical equivalence studies 5. Product function performance studies 6. Medical device and packaging stability studies 7. Degradability performance studies 8. Medical device and drug compatibility studies 9. Magnetic Resonance Imaging Compatibility Study (MRI) Microbiological testing and environmental testing of medical devices 1. Microbiological limit and sterility test 2. Bacterial endotoxin test 3. Medical device GMP production environment test 4. Purified water test 5. Biological safety cabinet, clean worktop test 6. Bacterial revert mutation test 7. Microbial barrier and antibacterial test Disinfection control and validation of medical devices 1. Cleaning, disinfection and sterilization verification 2. Sanitize and discard date verification Medical device aging verification 1. Shelf life verification of medical device products 2. Medical device transportation stability study 3. Packaging material expiration date study Active medical device electrical safety testing and EMC testing 1. Safety testing of medical electrical equipment (GB9706.1 series standard) 2. Safety testing of measurement control and laboratory equipment and in vitro diagnostic equipment (GB4793 series standard) 3. Electromagnetic compatibility testing (YY 9706.102, GB / T 18268.1, GB / T 18268.26) 4. Simulation of climatic environment and mechanical environment test 5. Product pre-test and rectification verification testing 6. Usability studies 7. Risk analysis studies 8. Performance and safety evaluation of post-marketing device use Medical software product consultation and testing 1. Testing of Software as a medical device (SaMD) and Software in a medical device (SiMD) 2. Medical device cybersecurity test 3. Quality assessment of health software 4. Individual performance tests for the quality of software products 5. Medical software usability test 6. Risk management, software development, software testing outsourcing and consulting services in the design and development stage 7. Programmable Medical Electrical Systems (PEMS) risk-related consulting services 8. Science and technology project acceptance test 9. Software product registry test In Vitro Diagnostic Products (IVD) 1. IVD product development and design services 2. IVD product performance testing services
泰格捷通(北京)医药科技有限公司
Beijing Tigermed-Jyton Co., LTD. ——Registration Testing Agent
We provide testing agency services for manufacturers with stereotyped products, assist companies to select appropriate national testing labs, write product technical requirements, submit testing materials, and provide advice on many aspects such as testing protocols, timeline planning, sample delivery requirements, rectification suggestions, etc., so as to track and ensure the testing progress.
泰格捷通(北京)医药科技有限公司
Beijing Tigermed-Jyton Co., LTD. ——Consulting Services
Depending on our clients' needs, we offer a wide range of customized consulting services, including but not limited to the following: 1) Regulatory Consultation 1. Medical device industry polices, updates and interpretation. 2. Global market access policies, updates and interpretation 2) Professional Training 1. Regulatory training 2. Quality management system training 3. Clinical trial management training 4. Other company-specific training 3) Medical Device Translation Services Our medical device translation team focuses on professional translation in the medical device industry, covering pre-market regulatory process, product testing, expert panel meeting, post-market surveillance, adverse events and other professional technical dossier translation, as well as simultaneous translation and conference interpretation services for various international medical device conferences. Our translation languages include English, Chinese, Japanese, German, French and other languages.
泰格捷通(北京)医药科技有限公司
Beijing Tigermed-Jyton Co., LTD. ——Product Strategy Planning
We assist our client in planning product registration strategy by distinguishing potential regulatory challenges and difficulties, and finding suitable paths to fast-track product commercialization, along with identifying estimated costs and timelines for all pivotal activities. We offer the following services: 1. Registration strategy analysis / Estimation of pre-registration costs and time 2. Registration execution strategy / Registration path risk assessment
泰格捷通(北京)医药科技有限公司
Beijing Tigermed-Jyton Co., LTD. ——Product Market Research
We can provide customers with market research services for designated products and provide product research reports, including product market size, competitive brands and competitive product analysis, target customer analysis, products’ medical insurance status, clinical use feedback, etc. The content of the report can be customized according to customer needs.
泰格捷通(北京)医药科技有限公司
Entity Management Services (Canada)
We provide corporate and entity management services to domestic and international clients. Collaborating closely with other law firms, tax advisors, and global service providers, we often act as our clients' single point of contact in Canada to deliver seamless corporate solutions. See: https://www.skylaw.ca/corporate-services
SkyLaw Professional Corporation
Securities Law Advice (Canada)
We offer strategic and proactive advice on securities law compliance involving both public and private issuers, including advice on prospectus exemptions, capital raising, control distributions and dissent rights. We can help prepare and file early warning reports, alternative monthly reports, reports of exempt distribution, press releases, SEDI (insider) filings and other materials.
SkyLaw Professional Corporation
Cross-border M&A (Canada)
We draw on deep experience to help buyers and sellers of both public and private businesses navigate complex M&A transactions and plans of arrangement, and to negotiate and close their deals. Leveraging our international experience and global network, we can coordinate or provide the right legal advice - wherever in the world it is needed.
SkyLaw Professional Corporation
Expatriate Work Permit / Residence Permit Support – South Africa
Equinox (EQN) is a pan-African business services platform delivering integrated corporate, compliance, tax, payroll and business support services through regional hubs in North, East, West and Southern Africa, with active engagements across 30+ African jurisdictions under a single-accountability model. Volume-based; excludes government / consular fees.
Equinox Group
Off-cycle Payroll Processing – South Africa
Equinox (EQN) is a pan-African business services platform delivering integrated corporate, compliance, tax, payroll and business support services through regional hubs in North, East, West and Southern Africa, with active engagements across 30+ African jurisdictions under a single-accountability model. Bonuses or recalculations; per-employee or 25% of monthly base, whichever higher.
Equinox Group
UIF / SDL Unemployment Insurance & Skills Development Levy Registration – South Africa (per New Employee)
Equinox (EQN) is a pan-African business services platform delivering integrated corporate, compliance, tax, payroll and business support services through regional hubs in North, East, West and Southern Africa, with active engagements across 30+ African jurisdictions under a single-accountability model. One-off UIF / SDL registration per new hire.
Equinox Group
Monthly Payroll Processing – South Africa (per Employee)
Equinox (EQN) is a pan-African business services platform delivering integrated corporate, compliance, tax, payroll and business support services through regional hubs in North, East, West and Southern Africa, with active engagements across 30+ African jurisdictions under a single-accountability model. Per-employee per-month processing; tiered by headcount.
Equinox Group
Payroll System Setup – South Africa
Equinox (EQN) is a pan-African business services platform delivering integrated corporate, compliance, tax, payroll and business support services through regional hubs in North, East, West and Southern Africa, with active engagements across 30+ African jurisdictions under a single-accountability model. One-time payroll setup; tiered by headcount (1–500).
Equinox Group
Reports & Guidelines
Access expert research reports, compliance guidelines, and authoritative documentation
A Director's Perspective: Exposure, Risks and Personal Liability
In this article, Mark Lee Chambers Law Corporation explores the fundamental paradox facing corporate leaders: while the company itself operates under the shield of limited liability, directors remain exposed to direct personal liability when breaching their duties.
Mark Lee Chambers Law Corporation
Shareholders' Agreement
This Article by Mark Lee Chambers Law Corporation explains the importance behind a well drafted and comprehensive agreement between shareholders and examines both the legal underpinnings of these contracts and explores practical options for allocating rights and liabilities across different business scenarios.
Mark Lee Chambers Law Corporation
Shareholder Disputes: Oppression, Buyout Orders, Share Valuation
This Article by Mark Lee Chambers Law Corporation explores both the legal and technical aspects of shareholder oppression claims and business / share valuations.
Mark Lee Chambers Law Corporation
Shareholder Decisions - The Power of the Vote
When corporate management is vested solely in the Board, can shareholders ever make business decisions for the company? This Article by Mark Lee Chambers Law Corporation examines the rare exceptions to this rule and outlines the factors courts consider when allowing shareholders to intervene in corporate management.
Mark Lee Chambers Law Corporation
Shareholder - The Concept of Rights & Liabilities
This Article by Mark Lee Chambers Law Corporation examines the legal relationship between a company and its shareholders post-incorporation, focusing on the specific rights shareholders retain when day-to-day management is vested entirely in the Board.
Mark Lee Chambers Law Corporation
Share Buyout - Applicability of Discounts
When courts find shareholder oppression, a share buyout is a common enough remedy to the aggrieved shareholder. This Article by Mark Lee Chambers Law Corporation discusses the circumstances under which valuation discounts may be applied when the court orders a buyout to remedy the oppression.
Mark Lee Chambers Law Corporation
Power to Grant Relief - A Director's Liability under Section 391 of the Companies Act 1967
This Article by Mark Lee Chambers Law Corporation explores the reliefs a director might seek under section 391 of the Companies Act 1967 when facing legal action for a breach of director's duties.
Mark Lee Chambers Law Corporation
Testifying from Outside Singapore - the Video Link Exception in Multi-Jurisdictional Disputes
With multi-jurisdictional disputes on the rise and the unavoidable need for witness testimony, this Article by Mark Lee Chambers Law Corporation explores the general principles and considerations factored by the Singapore Courts in deciding whether to exercise its discretion to receive oral evidence by video link in civil proceedings.
Mark Lee Chambers Law Corporation
Lifting the Veil of of Incorporation
This Article by Mark Lee Chambers Law Corporation discusses the concept of the separate legal personality following the incorporation of a company in Singapore.
Mark Lee Chambers Law Corporation
Investing in Singapore: A Foreign Investor's Guide
This Joint Article between Marigold Consultancy and Mark Lee Chambers Law Corporation presents a bite-sized roadmap for readers looking to expand or anchor their businesses in Singapore.
Mark Lee Chambers Law Corporation
Directors - The Concept of Duties & Liabilities
This Article by Mark Lee Chambers Law Corporation discusses the concept of directorships in Singapore and explains that while the law recognises only one form of directorship, in practice, there are several kinds of directors including executive and non-executive directors. All owe fiduciary duties to the company.
Mark Lee Chambers Law Corporation
Derivative Action by Shareholders
This Article by Mark Lee Chambers Law Corporation discusses the very common scenario of a deadlock between a company and its shareholders. We discuss specific circumstances where a shareholder's request for enforcement and accountability are rebuffed by the Board.
Mark Lee Chambers Law Corporation
Companies - Corporate Personality
This Article by Mark Lee Chambers Law Corporation provides an overview on how companies are incorporated in the Republic of Singapore and explains the effects of incorporation and the relationships between the company and its shareholders after incorporation.
Mark Lee Chambers Law Corporation
Case Update: Sakae Holdings Ltd [2018] SGCA 33
This Case Update by Mark Lee Chambers Law Corporation discusses the decision made by the highest court in the Republic of Singapore relating to minority oppression claims brought under Section 216 of the Companies Act 1967. The important distinction is drawn between personal wrongs suffered by a shareholder and corporate wrongs committed against the company, and in what situations may a finding of commercial unfairness be found to support a claim for oppression.
Mark Lee Chambers Law Corporation
Case Highlight: Reverse Oppression
This Case Highlight by Mark Lee Chambers Law Corporation discusses the topic of whether a majority shareholder may ever be "oppressed" by the minority.
Mark Lee Chambers Law Corporation
Case Highlight: Shareholder Oppression and the Relevance of a Buyout Remedy
This Case Highlight by Mark Lee Chambers Law Corporation discusses a decision made by the High Court of the Republic of Singapore to dismiss an application made by the majority shareholders to strike out a minority shareholder's claim for oppression, on grounds that a buyout offer had already been made. The majority shareholders' application was successfully resisted.
Mark Lee Chambers Law Corporation
Access to a Company's Documents & Records
This Article by Mark Lee Chambers Law Corporation explores a director's rights of inspection vis-a-vis company documents and the avenue one has when his/her entitlement is restricted.
Mark Lee Chambers Law Corporation
Legal Update – February 2026 – The Law on Investment 2025, Effective from 1 March 2026, Introduces Key Changes for Investors and Enterprises
The period from 2020 to 2025 has been marked by significant geopolitical volatility. Investment activities and global supply chains have undergone substantial restructuring. It is widely observed that investment flows in general, and next-generation foreign direct investment (FDI) in particular, are no longer primarily driven by low-cost advantages or short-term incentives. Instead, they are increasingly oriented toward jurisdictions offering stable investment environments, well-integrated political, social, environmental, and technological infrastructure, and a strong commitment to sustainable development standards.
Bizconsult Law Firm
Special Report on Nutrition and Health Foods for China’s Middle-Aged and Elderly Population
As China’s population aging continues to deepen, nutritional and health issues among the middle-aged and elderly have become increasingly prominent, making this an important component of advancing the Healthy China strategy. Demand from middle-aged and elderly consumers in the nutrition products sector continues to grow, driving steady expansion of the nutrition and health food market, while consumer needs are becoming increasingly diversified and precise. Against this backdrop, based on in-depth research into the field of nutrition and health for China’s middle-aged and elderly population, CIC and QuantumPharm/Quantum Song? Wait—need accurate translation. Better neutralize: CIC Insight Consulting and Quantum Song (NASDAQ: QSG) jointly released the 2024 China Middle-Aged and Elderly Nutrition and Health Food Report: Nourishing the Silver Years, Insights into the Consumption Landscape of Nutrition and Health Among Middle-Aged and Elderly Consumers. The report provides a comprehensive analysis of the current state of nutrition and health consumption among China’s middle-aged and elderly population, key trends and characteristics, consumer pain points, and future industry development trends.
China Insights Consultancy
White Paper on the New-Style Tea Beverage Industry
Recently, the 2nd China New-Style Tea Beverage Industry Conference, hosted by the China New-Style Tea Beverage Industry Alliance, was successfully held at the National Exhibition and Convention Center in Shanghai. During the conference, CIC, together with the China New-Style Tea Beverage Industry Alliance, jointly released the White Paper on the New-Style Tea Beverage Industry. Zhu Yue, Partner at CIC, attended as a representative of the invited consulting institution and joined more than 100 tea beverage brands from across the country to explore breakthrough paths under the theme of “Differentiation • A New Journey.” Zhu Yue stated that the new-style tea beverage industry is undergoing continuous innovation and transformation, and that the White Paper on the New-Style Tea Beverage Industry addresses issues of market concern from multiple perspectives, including recent investment hotspots, interpretation of the industry chain, and industry development trends, giving it important practical and strategic significance in the current environment. The white paper received strong attention and praise from conference guests and continued to generate significant interest after the event.
China Insights Consultancy
Courses
Structured, video-driven learning programs that combine expert instruction with real-world insights
Webinars
Join live and on-demand webinars led by industry leaders and subject-matter experts
Articles
Explore in-depth insights, thought leadership, and analysis from global experts
Events
Connect professionals, share expertise, and spark transformative ideas for the future
Platform
Learn more about Leadvisor Platform and explore essential resources, policies, and support
Consultants
Connect with a global community of expert consultants and trusted firms



















